Pooled data from belimumab RCTs w/>3,000 pts evaluating kidney outcomes vs PLBO Tagging off BLISS-LN, pooled analysis w/marginal but real benefit to adding BEL in pts with SLE I offer this to all pts w/SLE LN on MMF, but I do not push it #ACRbest #ACR22 @RheumNow #0352 https://t.co/QYGgB3ue36